BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23976958)

  • 1. Dopamine D1 receptor gene variation modulates opioid dependence risk by affecting transition to addiction.
    Zhu F; Yan CX; Wen YC; Wang J; Bi J; Zhao YL; Wei L; Gao CG; Jia W; Li SB
    PLoS One; 2013; 8(8):e70805. PubMed ID: 23976958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia.
    Zhu F; Yan CX; Wang Q; Zhu YS; Zhao Y; Huang J; Zhang HB; Gao CG; Li SB
    Brain Res; 2011 Oct; 1420():106-13. PubMed ID: 21955727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphisms in dopamine receptor D1 are associated with heroin dependence but not impulsive behavior.
    Liu JH; Zhong HJ; Dang J; Peng L; Zhu YS
    Genet Mol Res; 2015 Apr; 14(2):4041-50. PubMed ID: 25966176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of DRD1 with nicotine dependence.
    Huang W; Ma JZ; Payne TJ; Beuten J; Dupont RT; Li MD
    Hum Genet; 2008 Mar; 123(2):133-40. PubMed ID: 18092181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine Hydroxylase Gene Polymorphisms Contribute to Opioid Dependence and Addiction by Affecting Promoter Region Function.
    Liu JL; Li SQ; Zhu F; Zhang YX; Wu YN; Yang JS; Zhang B; Yan CX
    Neuromolecular Med; 2020 Sep; 22(3):391-400. PubMed ID: 32232669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype of the DRD1 gene is associated with alcohol dependence.
    Batel P; Houchi H; Daoust M; Ramoz N; Naassila M; Gorwood P
    Alcohol Clin Exp Res; 2008 Apr; 32(4):567-72. PubMed ID: 18341651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine receptor D1 gene is associated with the length of interval between first heroin use and onset of dependence in Chinese Han heroin addicts.
    Peng S; Du J; Jiang H; Fu Y; Chen H; Sun H; Wang D; Yu S; Zhao M
    J Neural Transm (Vienna); 2013 Nov; 120(11):1591-8. PubMed ID: 23661099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between opioid and dopamine receptor gene polymorphisms OPRM1 rs1799971, DAT VNTR 9-10 repeat allele, DRD1 rs4532 and DRD2 rs1799732 and alcohol dependence: an ethnicity oriented meta-analysis.
    Suresh N; Kantipudi SJ; Ramu D; Muniratnam SK; Venkatesan V
    Pharmacogenet Genomics; 2023 Sep; 33(7):139-152. PubMed ID: 37466123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control association analysis of dopamine receptor polymorphisms in alcohol dependence: a pilot study in Indian males.
    Prasad P; Ambekar A; Vaswani M
    BMC Res Notes; 2013 Oct; 6():418. PubMed ID: 24135011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels.
    Jacobs MM; Ökvist A; Horvath M; Keller E; Bannon MJ; Morgello S; Hurd YL
    Mol Psychiatry; 2013 Nov; 18(11):1205-10. PubMed ID: 23044706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association analysis between dopamine D1 receptor gene and symptom quantitative trait of schizophrenia].
    Zhang C; Wu ZG; Shao Y; Li ZZ; Yu SY; Fang YR
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2019-22. PubMed ID: 22093926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.
    Huo R; Wei Z; Xiong Y; Jiang J; Liu Y; Yan Y; Shi J; Li W; Cui D; Xing Q; He L; Qin S
    Neurosci Lett; 2015 Jan; 584():178-83. PubMed ID: 25179995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin delay discounting and impulsivity: Modulation by DRD1 genetic variation.
    Moses TEH; Burmeister M; Greenwald MK
    Addict Biol; 2020 May; 25(3):e12777. PubMed ID: 31192519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.
    Randesi M; van den Brink W; Levran O; Yuferov V; Blanken P; van Ree JM; Ott J; Kreek MJ
    Pharmacogenomics; 2018 Jan; 19(2):95-104. PubMed ID: 29210332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504.
    Huang W; Li MD
    Biol Psychiatry; 2009 Apr; 65(8):702-5. PubMed ID: 19135651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors.
    Sartor CE; Kranzler HR; Gelernter J
    Addict Behav; 2014 Feb; 39(2):473-9. PubMed ID: 24238782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.
    Blum K; Chen AL; Oscar-Berman M; Chen TJ; Lubar J; White N; Lubar J; Bowirrat A; Braverman E; Schoolfield J; Waite RL; Downs BW; Madigan M; Comings DE; Davis C; Kerner MM; Knopf J; Palomo T; Giordano JJ; Morse SA; Fornari F; Barh D; Femino J; Bailey JA
    Int J Environ Res Public Health; 2011 Dec; 8(12):4425-59. PubMed ID: 22408582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families.
    Hettinger JA; Liu X; Schwartz CE; Michaelis RC; Holden JJ
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):628-36. PubMed ID: 18205172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.
    Ota VK; Spíndola LN; Gadelha A; dos Santos Filho AF; Santoro ML; Christofolini DM; Bellucco FT; Ribeiro-dos-Santos ÂK; Santos S; Mari Jde J; Melaragno MI; Bressan RA; Smith Mde A; Belangero SI
    Schizophr Res; 2012 Dec; 142(1-3):206-8. PubMed ID: 23036699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.